Application 200626
- Type
- ANDA
- Sponsor
- CIPLA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 100MG BASE | No | No |
| 002 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 150MG BASE | No | No |
| 003 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 200MG BASE | No | No |
| 004 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 300MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A200626-001 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | 2018-08-09 | ||
| A200626-002 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2018-08-09 | ||
| A200626-003 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2018-08-09 | ||
| A200626-004 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2018-08-09 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A200626-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | 2018-08-09 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A200626-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2018-08-09 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A200626-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2018-08-09 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A200626-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2018-08-09 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A200626-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | 2018-08-09 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A200626-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2018-08-09 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A200626-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2018-08-09 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A200626-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2018-08-09 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A200626-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | 2018-08-09 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A200626-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2018-08-09 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A200626-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2018-08-09 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A200626-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2018-08-09 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A200626-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | 2018-08-09 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A200626-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2018-08-09 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A200626-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2018-08-09 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A200626-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2018-08-09 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A200626-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | 2018-08-09 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A200626-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | 2018-08-09 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A200626-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | 2018-08-09 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A200626-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | 2018-08-09 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A200626-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A200626-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A200626-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A200626-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A200626-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | 3f0d92c62455… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A200626-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | 3f0d92c62455… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A200626-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | 3f0d92c62455… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A200626-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A200626-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | 053a50430f4f… | |
| 2023-05-13 08:27 UTC | 2023-05 | A200626-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | 053a50430f4f… | |
| 2023-05-13 08:27 UTC | 2023-05 | A200626-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | 053a50430f4f… | |
| 2023-05-13 08:27 UTC | 2023-05 | A200626-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A200626-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | 3bdfa0b2c4d7… | |
| 2023-01-26 05:58 UTC | 2023-01 | A200626-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | 3bdfa0b2c4d7… | |
| 2023-01-26 05:58 UTC | 2023-01 | A200626-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | 3bdfa0b2c4d7… | |
| 2023-01-26 05:58 UTC | 2023-01 | A200626-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A200626-001 | ATAZANAVIR SULFATE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | 3a93d1ddd44b… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A200626-002 | ATAZANAVIR SULFATE | EQ 150MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | 3a93d1ddd44b… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A200626-003 | ATAZANAVIR SULFATE | EQ 200MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | 3a93d1ddd44b… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A200626-004 | ATAZANAVIR SULFATE | EQ 300MG BASE | CAPSULE / ORAL | AB | 2018-08-09 | 3a93d1ddd44b… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A200626-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A200626-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A200626-003 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A200626-004 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A200626-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A200626-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A200626-003 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A200626-004 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A200626-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A200626-002 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A200626-003 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A200626-004 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A200626-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A200626-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A200626-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A200626-004 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A200626-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A200626-002 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A200626-003 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A200626-004 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A200626-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A200626-002 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A200626-003 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A200626-004 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A200626-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A200626-002 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A200626-003 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A200626-004 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A200626-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A200626-002 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A200626-003 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A200626-004 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A200626-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A200626-002 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A200626-003 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A200626-004 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A200626-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A200626-002 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A200626-003 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A200626-004 | AB | 1 | c0c555d07b60… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atazanavir Sulfate | ATAZANAVIR | Aurobindo Pharma Limited | 7fbea274-d6b5-4faa-bbf0-05fefab42114 | 2025-08-06 | Warnings, Adverse reactions | Atazanavir Sulfate |
| Atazanavir Sulfate | ATAZANAVIR SULFATE | Teva Pharmaceuticals USA, Inc. | 654b7e08-33d8-47e7-b37f-3681e79c7b8b | 2024-12-30 | Warnings, Adverse reactions | Atazanavir Sulfate ATAZANAVIR SULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 69097-443 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-443 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-443 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-443 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-444 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-444 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-444 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-444 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-445 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-445 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-445 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-445 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-446 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-446 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-446 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-446 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 70518-2832 | ATAZANAVIR | Atazanavir | REMEDYREPACK INC. | ANDA | Current |
| 70518-2832 | ATAZANAVIR | Atazanavir | REMEDYREPACK INC. | ANDA | Current |